PharmaEssentia Corporation Stock LUXEMBOURG S.E.
Stocks
261280558
US7169721047
Biotechnology & Medical Research
|
End-of-day quote
LUXEMBOURG S.E.
16/10/2026
|
5-day change | 1st Jan Change | ||
| 38.40 USD | +3.23% |
|
+2.67% | +184.16% |
| Market Cap | 487B 15.01B 13.34B 12.37B 11.25B 21.23B 1,424B 21.57B 149B 58.28B 743B 56.33B 55.13B 2,370B | P/E 2026 * |
43.5x | P/E 2027 * | 27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 464B 14.3B 12.71B 11.78B 10.72B 20.23B 1,357B 20.55B 142B 55.52B 708B 53.66B 52.52B 2,257B | EV / Sales 2026 * |
17x | EV / Sales 2027 * | 10.9x |
| Free-Float |
79.23% | Yield 2026 * |
0.34% | Yield 2027 * | 0.2% |
| 1 day | +3.23% | ||
| 1 week | +2.67% | ||
| Current month | +0.52% | ||
| 1 month | +3.78% | ||
| 3 months | +3.78% | ||
| 6 months | +104.92% | ||
| Current year | +184.16% |
| 1 week | 36.2 |  | 38.4 |
| 1 month | 36.2 | | 38.4 |
| Current year | 14.05 | | 49.8 |
| 1 year | 13.06 | | 49.8 |
| 3 years | 8.55 | | 49.8 |
| 5 years | 7.97 | | 49.8 |
| 10 years | 7.97 | | 49.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 01/01/2017 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 14/10/2015 |
Cheng Ku Huang
PSD | President | - | 25/06/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
BRD | Director/Board Member | - | 09/05/2000 |
Ching-Leou Teng
CHM | Chairman | - | 24/09/2012 |
Cheng Ku Huang
BRD | Director/Board Member | - | 29/05/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.23% | +2.67% | - | - | 15.9B | |
| +1.52% | -7.16% | +51.66% | +67.41% | 65B | |
| +0.79% | +5.68% | +9.69% | +77.37% | 51.2B | |
| -0.25% | -0.82% | -0.38% | +61.31% | 51.19B | |
| -0.57% | +1.53% | +25.55% | +42.56% | 43.93B | |
| -0.12% | +6.03% | +16.62% | +134.15% | 41.96B | |
| -0.06% | -6.98% | +234.05% | +522.14% | 38.14B | |
| +2.16% | +10.36% | +18.92% | +59.70% | 33.24B | |
| -0.90% | -10.49% | +37.09% | +1.80% | 25.2B | |
| +1.32% | +2.17% | +27.91% | +27.95% | 22.5B | |
| Average | +0.77% | +0.14% | +46.79% | +110.49% | 41.37B | |
| Weighted average by Cap. | +0.63% | +0.04% | +45.04% | +111.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 27.23B 839M 746M 691M 629M 1.19B 79.64B 1.21B 8.31B 3.26B 41.56B 3.15B 3.08B 132B | 41.51B 1.28B 1.14B 1.05B 959M 1.81B 121B 1.84B 12.67B 4.97B 63.37B 4.8B 4.7B 202B |
| Net income | 10.93B 337M 299M 277M 252M 476M 31.96B 484M 3.34B 1.31B 16.68B 1.26B 1.24B 53.17B | 18.25B 562M 500M 463M 422M 796M 53.39B 808M 5.57B 2.18B 27.86B 2.11B 2.07B 88.81B |
| Net Debt | -23.05B -710M -631M -585M -532M -1B -67.42B -1.02B -7.04B -2.76B -35.18B -2.67B -2.61B -112B | -34.24B -1.06B -938M -870M -791M -1.49B -100B -1.52B -10.45B -4.1B -52.27B -3.96B -3.88B -167B |
| Date | Price | Change |
|---|---|---|
| 16/10/26 | USD 38.40 | +3.23% |
| 15/10/26 | USD 37.20 | +0.54% |
| 14/10/26 | USD 37.00 | +2.21% |
| 13/10/26 | USD 36.20 | -2.69% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6446 Stock
- 261280558 Stock
Select your edition
All financial news and data tailored to specific country editions
